C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2006
12/28/2006	WO2006138638A1 Methods and compositions for gene silencing
12/28/2006	WO2006138606A2 Cell signaling genes and related methods
12/28/2006	WO2006138527A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae
12/28/2006	WO2006138458A1 Cytotoxic ribonuclease variants
12/28/2006	WO2006138145A1 Nucleic acid functionalized nanoparticles for therapeutic applications
12/28/2006	WO2006138011A1 Method of transforming plants
12/28/2006	WO2006137941A2 Methods and compositions involving mirna and mirna inhibitor molecules
12/28/2006	WO2006137786A1 Hybridization-stabilizing construct
12/28/2006	WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances
12/28/2006	WO2006137595A1 Prophylactic/therapeutic agent for her2-expressing cancer
12/28/2006	WO2006137574A1 Cold-hardy plant and method for development of the same
12/28/2006	WO2006137551A2 Diagnostic method for cancer and diagnostic method for lung cancer
12/28/2006	WO2006137550A2 Diagnostic method for cancer and diagnostic method for lung cancer
12/28/2006	WO2006137517A1 Vector for gene transfer into young individual
12/28/2006	WO2006137515A1 Therapeutic agent for cancer comprising polypeptide capable of inhibiting the function of synoviolin as active ingredient
12/28/2006	WO2006137514A1 Therapeutic agent for cancer comprising substance capable of inhibiting expression or function of synoviolin as active ingredient and screening method for the therapeutic agent for cancer
12/28/2006	WO2006137487A1 GENE POLYMORPHISMS USEFUL IN ANTICIPATING RESPONSES TO β-BLOCKER DRUGS
12/28/2006	WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller
12/28/2006	WO2006137354A1 Antibody having inhibitory effect on amyloid fibril formation
12/28/2006	WO2006137283A1 Mutant glucose dehydrogenase
12/28/2006	WO2006137209A1 Dna, vector, transformant and method for producing apa protein
12/28/2006	WO2006137190A1 Photofunctional nucleic acid, method of producing the same and method of determining methylation
12/28/2006	WO2006137064A2 Constructs and methods for generating plants exhibiting altered plasmodesmatal conductance
12/28/2006	WO2006136831A2 Gene expression technique
12/28/2006	WO2006136697A2 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
12/28/2006	WO2006136640A1 Detection and identification of bacteriophages of lactic acid bacteria by means of multiple polymerase chain reaction (multi-pcr) and applications thereof
12/28/2006	WO2006136601A1 Optimization of west nile virus antibodies
12/28/2006	WO2006136596A2 Improved methods for the production of stably transformed, fertile zea mays plants
12/28/2006	WO2006136579A2 Expression cassettes for seed-preferential expression in plants
12/28/2006	WO2006136392A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy
12/28/2006	WO2006136383A1 Selection of phosphatase-coding nucleic acid molecules
12/28/2006	WO2006136351A2 Methods for altering the reactivity of plant cell walls
12/28/2006	WO2006136314A1 Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use
12/28/2006	WO2006136311A1 Metabolic engineering of q10 production in yeasts of the genus sporidiobolus
12/28/2006	WO2006136114A1 Amniotic cells and methods for use thereof
12/28/2006	WO2006136084A1 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses
12/28/2006	WO2006136033A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
12/28/2006	WO2006136006A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
12/28/2006	WO2006135985A1 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
12/28/2006	WO2006135974A1 Targeting vector
12/28/2006	WO2006121902A3 Interaction of glyphosate with photosystem ii inhibitor herbicides as a selection tool for roundup ready events
12/28/2006	WO2006119627B1 Enhancing vegetative protein production in transgenic plants using seed specific promoters
12/28/2006	WO2006113559A3 Methods for modulating bone formation and mineralization by modulating krc activity
12/28/2006	WO2006111372A3 Phytase
12/28/2006	WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006	WO2006097462A3 Compositions and methods for treating inflammatory cns disorders
12/28/2006	WO2006094976A3 Expression enhancing intron sequences
12/28/2006	WO2006091511A3 Primate t-lymphotropic viruses
12/28/2006	WO2006089911A3 Expression cassettes for seed-preferential expression in plants
12/28/2006	WO2006081060A3 Compositions and methods of use of response regulators
12/28/2006	WO2006074397A3 Cripto binding molecules
12/28/2006	WO2006070024A3 E1-minus adenoviruses and use thereof
12/28/2006	WO2006066134A3 Nucleotide sequences and polypeptides encoded thereby useful for enhancing plant drought tolerance
12/28/2006	WO2006063075A3 Hemipteran octopamine receptor
12/28/2006	WO2006050491A3 Methods for antibody engineering
12/28/2006	WO2006050038A3 Vesicle trafficking stress-related polypeptides and methods of use in plants
12/28/2006	WO2006045116A3 In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria
12/28/2006	WO2006044912A3 Scarecrow-like stress-related polypeptides and method sof use in plants
12/28/2006	WO2006040685A3 Methods for improving tree growth and wood properties
12/28/2006	WO2006013462A3 Growth factors nsg28, nsg30, and nsg32
12/28/2006	WO2005121367A8 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
12/28/2006	WO2005084712A3 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
12/28/2006	WO2005079271A3 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
12/28/2006	WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies
12/28/2006	WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene
12/28/2006	WO2004072239A3 Novel polypeptides with antifungal activity
12/28/2006	WO2004054517A3 Compositions and methods for inhibiting tumor growth and metastasis
12/28/2006	WO2003072714A3 Follistatin domain containing proteins
12/28/2006	US20060294627 Inbred corn line G0502
12/28/2006	US20060294623 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhanced shelf life; deoxyhypusine synthase (DHS)
12/28/2006	US20060294622 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/28/2006	US20060294621 Methods and compositions to modulate ethylene sensitivity
12/28/2006	US20060294619 Method for plant transformation based on thje pollination-fecundation pathway and the products thereof
12/28/2006	US20060294618 imparting virus resistance to plants by silencing a gene encoding a translation initiation factor eIF4E or by overexpressing in a plant a nucleic acid molecule encoding a heterologous eIF4E
12/28/2006	US20060294617 Zinc finger proteins for DNA binding and gene regulation in plants
12/28/2006	US20060294609 Production of cloned offspring from cooled carcasses
12/28/2006	US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy
12/28/2006	US20060294603 Cloning of transgenic animals comprising artificial chromosomes
12/28/2006	US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
12/28/2006	US20060294601 Compositions, organisms and methodologies employing a novel human kinase
12/28/2006	US20060293513 Phosphoserine phosphatase gene of coryneform bacteria
12/28/2006	US20060293512 Novel human uncoupling proteins and polynucleotides encoding the same
12/28/2006	US20060293510 Metal complex type nucleic acid
12/28/2006	US20060293506 Antibodies directed to PDGFD and uses thereof
12/28/2006	US20060293272 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060293271 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060293269 oligonucleotide with modified phosphorothioate linkage, sugar moiety, or nucleobase; disease or condition associated with expression of superoxide dismutase 1
12/28/2006	US20060293268 Antisense antiviral compounds and methods for treating foot and mouth disease
12/28/2006	US20060293262 inhibiting HIV entry into CCR5-expressing cells; treatment and prevention of infectious diseases or disorders, e.g., HIV infection, AIDS, and AIDS-related diseases
12/28/2006	US20060293239 Treatment and Diagnosis of Insulin-Resistant States
12/28/2006	US20060293230 Expression and secretion of icIL-1 receptor antagonist type II
12/28/2006	US20060293225 Gmg-2 polynucleotides and polypeptides and uses thereof
12/28/2006	US20060292691 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060292687 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time
12/28/2006	US20060292682 Addition of transgenes into adenoviral vectors
12/28/2006	US20060292678 Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof
12/28/2006	US20060292674 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis
12/28/2006	US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection
12/28/2006	US20060292671 utilizes mannitol, arabitol, glucitol, or glycerol to induce expression of a target polypeptide from an inducible promoter, allowing for the use of an inexpensive and stable carbon source inducer in the fermentation processes for the production of recombinant peptides
12/28/2006	US20060292670 Nell peptide expression systems and bone formation activity of nell peptide

1 ... 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 ... 4023